Cite
In-vitro acetylation of SARS-CoV and SARS-CoV-2 nucleocapsid proteins by human PCAF and GCN5.
MLA
Hatakeyama, Dai, et al. “In-Vitro Acetylation of SARS-CoV and SARS-CoV-2 Nucleocapsid Proteins by Human PCAF and GCN5.” Biochemical & Biophysical Research Communications, vol. 557, June 2021, pp. 273–79. EBSCOhost, https://doi.org/10.1016/j.bbrc.2021.03.173.
APA
Hatakeyama, D., Masuda, T., Miki, R., Ohtsuki, S., & Kuzuhara, T. (2021). In-vitro acetylation of SARS-CoV and SARS-CoV-2 nucleocapsid proteins by human PCAF and GCN5. Biochemical & Biophysical Research Communications, 557, 273–279. https://doi.org/10.1016/j.bbrc.2021.03.173
Chicago
Hatakeyama, Dai, Takeshi Masuda, Ryosuke Miki, Sumio Ohtsuki, and Takashi Kuzuhara. 2021. “In-Vitro Acetylation of SARS-CoV and SARS-CoV-2 Nucleocapsid Proteins by Human PCAF and GCN5.” Biochemical & Biophysical Research Communications 557 (June): 273–79. doi:10.1016/j.bbrc.2021.03.173.